- cafead   Jul 19, 2022 at 10:42: AM
via Preliminary results from Innovent Biologics' Phase II trial of mazdutide, a potential treatment for type 2 diabetes, showed the drug met its primary endpoint by successfully reducing HbA1c levels versus placebo after 20 weeks of treatment.
article source
article source